LIN SUE-JEAN 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
LIN SUE-JEAN
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-09+25,723→ 25,723 totalExercise: $27.77Exp: 2031-06-09→ Common Stock (25,723 underlying)
Footnotes (1)
- [F1]The option vests as to 1/3rd of the total shares on each of June 9, 2022, June 9, 2023 and June 9, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date.